Antimicrobial Resistance (AMR)
The Challenge
Our client currently offers one of the largest and most diverse anti-infective portfolios in the industry, and seeks to continue growing globally.
One strategic priority for the client is to develop and execute a global patient engagement and advocacy campaign, with the goal of enabling advocates to address key challenges including the rising public health threat posed by anti-microbial resistance (AMR).
Our Solution
Our approach to this multi-year project is as follows:
Identify and prioritize key global anti-infective advocacy organizations and stakeholders.
Develop a patient engagement strategy and toolkit.
Collaborate with patient organizations across disease areas and regions to develop and execute AMR awareness and advocacy programs.
Form and facilitate regular AMR Global Patient Council meetings; collaborate on key initiatives.
Lead and facilitate annual Patient Summits to raise awareness and accelerate advocacy efforts.
Create global AMR Patient Consensus document.
Support creation of global AMR Patient Alliance.
Create patient education and advocacy resources.
benefits to the client
Influential Advocacy Network: Identify and build relationships with influential Anti-Infective (AI) patient advocacy community.
Global Advocacy Enablement: Educate and enable a global patient community group to effectively advocate for important AI policies in their regions.
Leadership Establishment: Establish and maintain leadership in novel development of anti-infective products as well as in improving public health issues such as anti-microbial resistance (AMR).
DKI DIFFERENCE
Over the past five years, DKI Health has dedicated its efforts to establishing a robust global patient advocacy community focused on mitigating the risk of antimicrobial resistance (AMR) across various health conditions. This initiative resulted in the formation of the AMR Patient Alliance, with whom we collaboratively developed the Global Patient Consensus Statement on AMR. These advocates play a critical role in educating broader communities about the dangers of AMR and championing enhanced policies to improve the management of antimicrobial resistance worldwide.